Literature DB >> 6477797

Labetalol and phaeochromocytoma.

M Navaratnarajah, D C White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6477797     DOI： 10.1093/bja/56.10.1179

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  4 in total

1.  The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.

Authors:  R Sheaves; S L Chew; A B Grossman
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

2.  Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraganglioma.

Authors:  M Pulcrano; E A Palmieri; L Pagano; L Tauchmanova; A Rossi; S Fazio; G Lombardi; B Biondi
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

3.  Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.

Authors:  T Yamaguchi; C Irisawa; H Watanabe; S Kawamura; T Nakada
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

4.  Guidelines for the drug treatment of hypertensive crises.

Authors:  M M Hirschl
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.